Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.29 USD | +1.33% | +7.76% | -81.59% |
May. 14 | Transcript : Vivos Therapeutics, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Vivos Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-81.59% | 6.83M | |
+73.24% | 12.39B | |
-19.09% | 7.89B | |
+13.24% | 5.43B | |
+38.48% | 4.96B | |
-17.14% | 4.72B | |
-18.76% | 4.02B | |
-29.53% | 2.66B | |
+47.29% | 2.37B | |
-2.10% | 1.96B |
- Stock Market
- Equities
- VVOS Stock
- News Vivos Therapeutics, Inc.
- Vivos Therapeutics : Roth Capital Starts Vivos Therapeutics at Buy With $12 Price Target